Subscribe for the latest consumer trends, trade news, nutrition science and regulatory updates in the supplement industry!
Join 37,000+ members. Yes, it's completely free.
Terry Laboratories
March 12, 2007
1 Min Read
MELBOURNE, Fla.—GlySync is a new ingredient for fighting diabetes, according to Terry Laboratories (www.terrylabs.com). The all-natural compound reduces insulin resistance and assists with glucose regulation, offering consumers reduced risk of hypoglycemia and hyperglycemia with a potential reduction in low-density lipoprotein (LDL) cholesterol. GlySync is derived from Nopal extract of the Opuntia streptacantha cactus leaf and is a natural source of antioxidants, detoxifiers, hormone modifiers, and vitamins A, E, C and the B complex.
You May Also Like